Fundraising Fox

Jonathan Ilicki

Investor

Investment Manager at Industrifonden

Sweden

About

Jonathan Ilicki is part of Industrifonden's life science team, with a background spanning clinical practice, research, entrepreneurship, and management consulting. He previously worked as a physician, co-founded a medtech startup, scaled operations for a digital healthcare provider, and led growth and internationalization for a VC/PE-backed healthtech scale-up. He holds an MD from Karolinska Institutet, an Executive MBA from the Stockholm School of Economics, and a master's degree in Evidence-Based Medicine from the University of Gothenburg.

Contact· self-published, not guessed

Invests in

BiotechDigital HealthHealthtechMedical Devices

Experience

  1. IndustrifondenInvestment Managercurrent2025 — present
  2. IndustrifondenPrincipal2023 — 2024
  3. German Marshall Fund of the United StatesMarshall Memorial Fellowcurrent2026 — present
  4. ToxoTech ABBoard Membercurrent2026 — present
  5. ZymegoBoard Membercurrent2025 — present
  6. Tribune TherapeuticsBoard Membercurrent2025 — present
  7. Gesynta Pharma ABBoard Observercurrent2025 — present
  8. BOOST PharmaBoard Membercurrent2024 — present
  9. VitalaBoard Membercurrent2024 — present
  10. ElyptaBoard Observercurrent2024 — present
  11. Hypocampus ABBoard Membercurrent2022 — present
  12. ZalVac ABBoard Member2025 — 2026
  13. Obama FoundationObama Europe Leader2024 — 2025
  14. Geras SolutionsBoard Member2022 — 2024
  15. Platform24Head of Growth2021 — 2023
  16. Platform24Head of Innovation2019 — 2023
  17. Platform24Head of Medical Content, acting2020 — 2021
  18. Ortrud Medical ABBoard Member2015 — 2023
  19. Ortrud Medical ABCEO and Co-founder2015 — 2017Stockholm, Sweden
  20. Doktor24Head of Medical Operations2018 — 2019
  21. The Boston Consulting Group (BCG)Associate2017 — 2018
  22. Karolinska University HospitalMedical Intern (AT) and Emergency Medicine Resident2013 — 2017
  23. Karolinska University HospitalJunior Doctor2012 — 2013Stockholm, Sweden
  24. Sveriges yngre läkares förening (SYLF)Board Member and Editor-in-Chief2012 — 2013Greater Stockholm Metropolitan Area
  25. Medicor; Medicinska Föreningen, Karolinska InstitutetEditor-in-Chief2008 — 2009Stockholm, Sweden

Skills & more

Strategy51Management64Analysis35Strategic Planning22Public Speaking36Team Leadership31Software as a Service (SaaS)3Entrepreneurship56Start-ups36Clinical Research40Public Health40Healthcare40
+12 moreProject ManagementHospitalsBusiness StrategyBusiness-to-Business (B2B)Healthcare Information TechnologyBusiness DevelopmentLife SciencesResearchEpidemiologyMedicineManagement ConsultingMedical Education

From Jonathan's professional profile.

Investments

Per the firm's website.

Colleagues at Industrifonden

Frequently asked questions

Who is Jonathan Ilicki?
Jonathan Ilicki is part of Industrifonden's life science team, with a background spanning clinical practice, research, entrepreneurship, and management consulting. He previously worked as a physician, co-founded a medtech startup, scaled operations for a digital healthcare provider, and led growth and internationalization for a VC/PE-backed healthtech scale-up. He holds an MD from Karolinska Institutet, an Executive MBA from the Stockholm School of Economics, and a master's degree in Evidence-Based Medicine from the University of Gothenburg.
Where does Jonathan Ilicki work?
Jonathan Ilicki is Investment Manager at Industrifonden.
What does Jonathan Ilicki invest in?
Jonathan Ilicki invests in Biotech, Digital Health, Healthtech, Medical Devices.
What companies has Jonathan Ilicki invested in?
Investments tracked here include Airsonett, Asgard Therapeutics, BOOST Pharma, Elypta, Gesynta Pharma, Nuvoair, Toxotech, Tribune Therapeutics AB, Zymego.
Where did Jonathan Ilicki go to school?
Jonathan Ilicki studied at Stockholm School of Economics (Executive MBA); MIT Sloan School of Management (Artificial Intelligence in Health Care Executive Course); University of Cambridge (High Impact Leadership Executive Course. Grade: Excellent (97%)).

Same school

Shared employers